Minimalist IAS
Sign upसाइन अप
2017 GS Paper III

UPSC CSE (Main) 2017 · GS Paper III · Question 6

Stem cell therapy is gaining popularity in India to treat a wide variety of medical conditions including…

UPSC Civil Services (Main) Examination 2017, General Studies Paper III (GS 3), Question 6 — 10 marks, 150 words.

Syllabus line: IT, space, robotics, biotech & IPR — “Awareness in the fields of IT, Space, Computers, robotics, nano-technology, bio-technology and issues relating to intellectual property rights.”

GS Paper III 2017 · Q6

10 marks · 150 words IT, space, robotics, biotech & IPR X-Ray · Core #26

Stem cell therapy is gaining popularity in India to treat a wide variety of medical conditions including Leukaemia, Thalassemia, damaged cornea and severe burns. Describe briefly what stem cell therapy is and what advantages it has over other treatments ?

Approach · directive: “describe / what advantages”

What it asks · Say briefly what stem cell therapy is and list its advantages over conventional treatments.

It asks 2 things — answer each

  1. Describe briefly what stem cell therapy is
  2. What advantages it has over other treatments

Open with · Definition plus data: stem cells are unspecialised cells that renew themselves and can become blood, skin or corneal cells; with 10,000–15,000 babies born with thalassaemia major every year (NHM), India has a large stake in therapies that repair rather than manage.

Cover

  • What it is: stem cells from bone marrow, cord blood, tissue or lab-reprogrammed cells (induced pluripotent stem cells, 2012 Nobel Prize to Gurdon and Yamanaka) are given to replace or repair damaged cells and tissues.
  • Uses: blood stem cell transplant treats leukaemia and thalassaemia; limbal stem cells restore the cornea; cultured skin cells help in severe burns.
  • Advantage: it repairs or replaces damaged tissue, so it can cure conditions that drugs only manage.
  • Advantage: using the patient's own cells lowers rejection risk, and it eases dependence on scarce donor organs and repeated transfusions.
  • Advantage: it opens a route for diseases with few options, such as certain blood, eye and spinal disorders, with fewer long-term drug effects.
  • Cautions: the ICMR-DBT National Guidelines (2017) permit only haematopoietic stem cell transplant for blood disorders as therapy; everything else is investigational, allowed only within approved clinical trials.

Close with · Stem cells promise regenerative medicine, but the road from bench to bedside must run through registered trials and ICMR's evidence-based status reviews, so that hope is not sold by unproven clinics.

Add value (verified)

Question: UPSC's CS (Main) 2017, GS Paper III — paper ↗. Approach: Minimalist IAS, checked 3 Oct 2026 (how we verify) — UPSC publishes no model answers. ·

Model answer· 223words · Minimalist IAS

Stem cells are unspecialised cells that renew themselves and can become blood, skin or corneal cells. With 10,000–15,000 babies born with thalassaemia major every year (NHM), India has a large stake in therapies that repair rather than manage.

What stem cell therapy is

  • Sources: bone marrow, umbilical cord blood, tissue, or adult cells reprogrammed into induced pluripotent stem cells, the discovery behind the 2012 Nobel Prize to Gurdon and Yamanaka.
  • Method and uses: cells are infused or grafted to rebuild damaged tissue: haematopoietic (blood) stem cell transplant for leukaemia and thalassaemia, limbal cells for the cornea, cultured skin for burns.

Advantages over other treatments

ConditionConventional careStem cell route
Thalassaemialifelong transfusionsone-time marrow transplant
Damaged corneadonor graftpatient's own limbal cells
  • Cure, not control: it replaces lost tissue, so it can cure what drugs only manage.
  • Lower rejection: the patient's own cells avoid immune rejection and lifelong immunosuppressants.
  • Less dependence: on scarce donor organs and repeated transfusions that bring infection and iron overload.

Cautions

  • Regulation: the ICMR-DBT National Guidelines (2017) permit only haematopoietic transplant for blood disorders as therapy; all else is investigational, allowed only in approved clinical trials.

Stem cells promise regenerative medicine, but the road from bench to bedside must run through registered trials and ICMR's evidence-based status reviews, so that hope is not sold by unproven clinics.

Prepared by Minimalist IAS to the answer standard of Shivam Singh (mentor, 7 years) · facts checked against official sources (how we verify) · updated 3 Oct 2026. UPSC publishes no model answers: compare your structure and coverage with this, then write your own.

Cite this question: UPSC CSE Mains GS-3 2017, Q6 — minimalistias.com/pyqs/mains/2017/gs3/q6 Discuss on WhatsApp

Write it now · 7 minutes for 150 words, by hand, as in the exam 07:00
Free · 3 answers on us Write this answer — get it evaluated free Handwrite it in 150 words, scan it into one PDF, and get a score and remarks from a mentor within 72 hours. Write it

Also asked on this syllabus line

All questions on IT, space, robotics, biotech & IPR →

Build the base: Prelims PYQs on this

Free · Daily Updates Join Minimalist IAS on Telegram or WhatsApp A PYQ every morning, the Daily Brief and the Sunday quiz. Free, no sign-up. Join Telegram Join on WhatsApp →